289 related articles for article (PubMed ID: 29467236)
21. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors.
Löhle M; Hermann A; Glass H; Kempe A; Schwarz SC; Kim JB; Poulet C; Ravens U; Schwarz J; Schöler HR; Storch A
Stem Cells; 2012 Mar; 30(3):570-9. PubMed ID: 22213586
[TBL] [Abstract][Full Text] [Related]
22. Cellular Ontogeny and Hierarchy Influence the Reprogramming Efficiency of Human B Cells into Induced Pluripotent Stem Cells.
Muñoz-López Á; van Roon EH; Romero-Moya D; López-Millan B; Stam RW; Colomer D; Nakanishi M; Bueno C; Menendez P
Stem Cells; 2016 Mar; 34(3):581-7. PubMed ID: 26850912
[TBL] [Abstract][Full Text] [Related]
23. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
[TBL] [Abstract][Full Text] [Related]
24. The miR-302-Mediated Induction of Pluripotent Stem Cells (iPSC): Multiple Synergistic Reprogramming Mechanisms.
Ying SY; Fang W; Lin SL
Methods Mol Biol; 2018; 1733():283-304. PubMed ID: 29435941
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic Aberrations Are Not Specific to Transcription Factor-Mediated Reprogramming.
Tiemann U; Wu G; Marthaler AG; Schöler HR; Tapia N
Stem Cell Reports; 2016 Jan; 6(1):35-43. PubMed ID: 26711876
[TBL] [Abstract][Full Text] [Related]
26. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
Heng BC; Fussenegger M
Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-Mediated Reprogramming of Somatic Cells into Induced Pluripotent Stem Cells.
Sandmaier SE; Telugu BP
Methods Mol Biol; 2015; 1330():29-36. PubMed ID: 26621586
[TBL] [Abstract][Full Text] [Related]
28. Efficient generation of induced pluripotent stem cells from human bone marrow mesenchymal stem cells.
Yulin X; Lizhen L; Lifei Z; Shan F; Ru L; Kaimin H; Huang H
Folia Biol (Praha); 2012; 58(6):221-30. PubMed ID: 23438847
[TBL] [Abstract][Full Text] [Related]
29. Human transgene-free amniotic-fluid-derived induced pluripotent stem cells for autologous cell therapy.
Jiang G; Di Bernardo J; Maiden MM; Villa-Diaz LG; Mabrouk OS; Krebsbach PH; O'Shea KS; Kunisaki SM
Stem Cells Dev; 2014 Nov; 23(21):2613-25. PubMed ID: 25014361
[TBL] [Abstract][Full Text] [Related]
30. Induced pluripotent stem cells (iPSCs) derived from frontotemporal dementia patient's peripheral blood mononuclear cells.
Lee HK; Morin P; Wells J; Hanlon EB; Xia W
Stem Cell Res; 2015 Sep; 15(2):325-7. PubMed ID: 26246272
[TBL] [Abstract][Full Text] [Related]
31. Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease.
Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Mar; 27():82-85. PubMed ID: 29334630
[TBL] [Abstract][Full Text] [Related]
32. Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.
Bueno C; Sardina JL; Di Stefano B; Romero-Moya D; Muñoz-López A; Ariza L; Chillón MC; Balanzategui A; Castaño J; Herreros A; Fraga MF; Fernández A; Granada I; Quintana-Bustamante O; Segovia JC; Nishimura K; Ohtaka M; Nakanishi M; Graf T; Menendez P
Leukemia; 2016 Mar; 30(3):674-82. PubMed ID: 26500142
[TBL] [Abstract][Full Text] [Related]
33. Generation of high quality of hepatocyte-like cells from induced pluripotent stem cells with Parp1 but lacking c-Myc.
Huang CS; Lin HC; Lu KH; Wu WW; Yang YC; Yang YP; Chiang CH; Hsieh JH; Chang YL; Lee SD
J Chin Med Assoc; 2018 Oct; 81(10):871-877. PubMed ID: 30017813
[TBL] [Abstract][Full Text] [Related]
34. Importance of Myc-related microRNAs in induced pluripotency.
Çağlayan ES; Güran Ş
Cell Biol Int; 2015 Sep; 39(9):987-94. PubMed ID: 25809132
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide gene expression analyses reveal unique cellular characteristics related to the amenability of HPC/HSCs into high-quality induced pluripotent stem cells.
Gao S; Tao L; Hou X; Xu Z; Liu W; Zhao K; Guo M; Wang H; Cai T; Tian J; Gao S; Chang G
Stem Cell Res Ther; 2016 Mar; 7():40. PubMed ID: 26979597
[TBL] [Abstract][Full Text] [Related]
36. H1foo Has a Pivotal Role in Qualifying Induced Pluripotent Stem Cells.
Kunitomi A; Yuasa S; Sugiyama F; Saito Y; Seki T; Kusumoto D; Kashimura S; Takei M; Tohyama S; Hashimoto H; Egashira T; Tanimoto Y; Mizuno S; Tanaka S; Okuno H; Yamazawa K; Watanabe H; Oda M; Kaneda R; Matsuzaki Y; Nagai T; Okano H; Yagami KI; Tanaka M; Fukuda K
Stem Cell Reports; 2016 Jun; 6(6):825-833. PubMed ID: 27237376
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of Brm and Baf170, Components of Chromatin Remodeling Complex, Facilitates Reprogramming of Somatic Cells.
Jiang Z; Tang Y; Zhao X; Zhang M; Donovan DM; Tian XC
Stem Cells Dev; 2015 Oct; 24(19):2328-36. PubMed ID: 26121422
[TBL] [Abstract][Full Text] [Related]
38. Re-entering the pluripotent state from blood lineage: promises and pitfalls of blood reprogramming.
Chen Y; Yi Y; Xu J; Chan WK; Loh YH
FEBS Lett; 2019 Dec; 593(23):3244-3252. PubMed ID: 31691960
[TBL] [Abstract][Full Text] [Related]
39. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
[TBL] [Abstract][Full Text] [Related]
40. Sox2 expression effects on direct reprogramming efficiency as determined by alternative somatic cell fate.
Yamaguchi S; Hirano K; Nagata S; Tada T
Stem Cell Res; 2011 Mar; 6(2):177-86. PubMed ID: 21130722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
